IVI Valencia
Valencia, 46117, Spain
NCT Number: NCT00547781
The aim of this study is to performed a randomized controlled trial to evaluate the usefulness of preimplantation genetic diagnosis (PGD) in patients with repetitive implantation failure. Patients will be prospectively randomized in two groups: standard IVF with blastocyst transfer on day-5 and transfer day-5 after PGD for aneuploidy screening for chromosomes 13, 15, 16, 18, 21, 22, X and Y. The end points of the study are: Cancellation rate; implantation rate and ongoing implantation rate. Inclusion criteria are: patients with ≥2 previous IVF failure without clinical or biochemical pregnancy with transfer of at least 2 good quality embryos per transfer. Exclusion criteria will be uterine abnormalities , abnormal karyotypes, abnormal result in thrombophilia screening and low responder patients (less than 4 expected oocytes).
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 4
Valencia, 46117, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Instituto Valenciano de Infertilidad, IVI VALENCIA
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07008079
Dental Implant, Dental Implant Placement
Riyadh, Saudi Arabia
View Trial DetailsNCT06544837
ENDOMETRIAL RECEPTIVITY, IVF
Hanoi, Vietnam
View Trial DetailsNCT05798624
Genital Diseases, Implantation
Abu Dhabi, United Arab Emirates
View Trial Details